Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Visceral Leishmaniasis in Iran: An Update on Epidemiological Features From 2013 to 2022



Mohebali M1, 2 ; Edrissian G1 ; Akhoundi B1 ; Shirzadi M2, 3 ; Hassanpour G2 ; Behkar A2 ; Rassi Y4 ; Hajjaran H1 ; Keshavarz H1, 2 ; Gouya MM3 ; Arshi S3 ; Zeinali M3 ; Zarei Z1, 5 ; Sharifi I6 Show All Authors
Authors
  1. Mohebali M1, 2
  2. Edrissian G1
  3. Akhoundi B1
  4. Shirzadi M2, 3
  5. Hassanpour G2
  6. Behkar A2
  7. Rassi Y4
  8. Hajjaran H1
  9. Keshavarz H1, 2
  10. Gouya MM3
  11. Arshi S3
  12. Zeinali M3
  13. Zarei Z1, 5
  14. Sharifi I6
  15. Kakooei Z1
Show Affiliations
Authors Affiliations
  1. 1. Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Center for Research of Endemic Parasites of Iran (CREPI), Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Center for Communicable Diseases Management, Ministry of Health Treatment and Medical Education, Tehran, Iran
  4. 4. Department of Vector Biology and Control of Diseases, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Meshkin-Shahr Health Station from the School of Public Health, Tehran University of Medical Sciences, Ardebil, Iran
  6. 6. Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran

Source: Iranian Journal of Parasitology Published:2023

Abstract

Background: Visceral leishmaniasis (VL) is one of the most important neglected tropical diseases. The zoonotic form of VL is endemic in some areas of Iran. We aimed to determine the status of VL identified in humans and canines in different parts of Iran from 2013 to 2022. Method: A national representative cross-sectional study was conducted in 10 provinces of Iran, including the national leishmaniasis reference lab. We employed the direct agglutination test (DAT) as a reliable serological method to detect anti-Leishmania infantum antibodies in humans and animal reservoir hosts. Additionally, a narrative literature review was conducted to identify relevant studies on VL seroprevalence in Iran from 2013 to 2023. Results: The results of 21281 human and 5610 canine serum samples from 2013 to 2022 are reported. Altogether, 448 (2.1%, 95%CI: 2.0-2.3) human serum samples showed anti-L. infantum antibody levels of ≥1:3200. Of these samples, 13716 (64.5%) were collected actively, which showed a sero-prevalence of 0.6% (95% CI: 0.5-0.8) and 7565 (35.5%) were collected passively, which showed a seroprevalence of 4.8% (95%CI: 4.3-5.3). Overall, 1035 (20.1%, 95%CI: 19.0-21.2) of 5160 domestic dogs (Canis familiaris) samples showed anti-L. infantum antibody levels of ≥1:320. Northwest (٢٫٨%) and northeast (0.96%) regions had the highest human VL seroprevalence, while northwest (21.5%) and south (14.4%) regions had the highest canine VL seroprevalence. Conclusion: Zoonotic VL, an endemic parasitic disease, is still present in several different distinct areas across Iran. While human VL cases have shown a declining trend over the last decade, the prevalence of canine VL remains significant. © 2023 Mohebali et al.
Other Related Docs
33. Visceral Leishmaniasis in Southeastern Iran: A Narrative Review, Iranian Journal of Parasitology (2017)
42. Mapping and Review of Leishmaniasis, Its Vectors and Main Reservoirs in Iran, Journal of Kerman University of Medical Sciences (2015)